Rhythm Pharmaceuticals, Inc. (RYTM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 6.96B |
| Enterprise Value | 7.15B |
| P/E Ratio | -32.39 |
| PEG Ratio | 2.66 |
| Price/Sales Ratio | 32.02 |
| Price/Book Ratio | 56.07 |
| Enterprise/Revenue | 32.78 |
| Enterprise/EBITDA | -39.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.93 |
| Operating Margin | -0.91 |
| Return On Assets | -0.46 |
| Return On Equity | -2.03 |
| Revenue | 189.76M |
| Revenue/Share | 3.19 |
| Gross Profit | 170.27M |
| EBITDA | -174.12M |
| Net Income | -196.54M |
| Diluted EPS | -3.11 |
| Total Cash | 340.63M |
| Total Cash/Share | 5.01 |
| Total Debt | 227.02M |
| Total Debt/Equity | 1.85 |
| Current Ratio | 4.17 |
| Book Value Per Share | 1.81 |
| 52-Week Change | 63.19 |
| 52-Week High | 122.2 |
| 52-Week Low | 60.8 |
| Moving Average 50 Days | 88.36 |
| Moving Average 200 Days | 97.77 |
| Average Volume | 785,382 |
| Shares Outstanding | 68.59M |
| % Held by Institutions | 110.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |